FOI 051 - 2024

In relation to the determination of self-amplifying mRNA (sa-mRNA) as a GMO, provide:

• All documentation since 01 January 2018, including OGTR internal or external correspondence, concerning the interpretation and application of the Gene Technology Act and Gene Technology Regulations as applicable to injectable sa-mRNA vaccines for use in Humans.
• In relation to the Gene Technology Act’s definition of ‘organism’, all documentation since 01 January 2018, including OGTR internal or external correspondence, on which the OGTR has determined that injectable sa-mRNA vaccines for use in Humans are capable of reproduction.
• All documentation since 01 January 2018, including OGTR internal or external correspondence, on which the OGTR has based their position that injectable sa-mRNA vaccines for use in Humans have an innate capacity to transfer genetic material.